Stay updated on ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:02:25.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification in the context of a Phase 1/2 clinical trial involving the assessment of the safety and tolerability of ARV-110 in patients with metastatic castration-resistant prostate cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:48.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as age, gender, health condition, and prior treatments. Previously, no information was provided in this section.
    Difference
    28%
    Check dated 2024-05-22T21:02:34.000Z thumbnail image
  8. Check
    41 days ago
    Change Detected
    Summary
    The change on the webpage represents an update in the estimated study completion date from November 30, 2024, to a new value.
    Difference
    0.1%
    Check dated 2024-05-06T17:32:07.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Summary
    The value for the Study Completion date on the webpage has changed from an estimated date of November 30, 2024, to an actual date of April 29, 2024. This change indicates that the study was completed earlier than initially expected.
    Difference
    1%
    Check dated 2024-05-04T09:46:49.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:28:42.000Z thumbnail image

Stay in the know with updates to ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-110 in mCRPC: Metastatic Prostate Cancer Clinical Trial page.